Am. Avunduk et al., Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis, OPHTHALMOLA, 215(4), 2001, pp. 290-293
Purpose: To investigate the possible effects of topical cyclosporine eye dr
ops 2% (CsA) on conjunctival immune cells obtained by impression cytology t
echnique and to determine the clinical relevance of this effect if present.
Methods: Ten consecutive patients with severe, resistant, and active verna
l keratoconjunctivitis (VKC) were included in this study. All of them were
treated with 2% of topical CsA drops. Symptom and clinical scores and conju
nctival impression cytology specimens were obtained both before and followi
ng treatment. Impression cytology specimens were stained with anti-CD8+, CD
4+, CD45RA+, and CD23+ antibodies and the percentages of positive cells wer
e counted. The results were compared and correlation analyses were performe
d between clinical and laboratory data. Results: Significant reductions wer
e observed with respect to the percentages of CD4+ and CD23+ cells in the c
onjunctival impression cytology specimens and clinical and symptom scores f
ollowing treatment with topical CsA, while no change occurred in the percen
tages of CD8+ and CD45RA+ cells. The percentages of CD4+ and CD23+ cells sh
owed good correlations with symptom and clinical scores. Conclusion: Topica
l CsA treatment is a very effective alternative in severe VKC cases in clin
ical ground and clinical efficacy of topical CsA treatment in severe, resis
tant VKC cases can be (at least partly) related to reduction of the CD23+ a
nd CD4+ cell populations on the conjunctival surface. Copyright (C) 2001 S.
KargerAG, Basel.